Although COVID-19 outcomes have improved over the pandemic for patients with RA, some
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …

Immunoglobulin G4-related disease (IgG4-RD) is a chronic fibro-inflammatory disease that
may cause dysfunction in various organs. Worldwide multidisciplinary experts attending the …

Objective Rheumatic disease patients on certain immunomodulators are at increased risk of
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …

Background Rheumatoid arthritis has been associated with severe COVID-19, but few
studies have investigated how phenotypes of rheumatoid arthritis affect these associations …

Objectives To investigate coronavirus disease 2019 (COVID-19)-associated risk of
hospitalization and death in RA, AS, PsA, SLE and SSc in comparison with the general …

Objectives We aimed to investigate the role of rheumatoid arthritis (RA) with biologic or
targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) exposure in COVID …

Objectives: We aimed to analyse the incidence and severity of breakthrough infections (BIs)
in rheumatoid arthritis (RA) patients after a COronaVIrus Disease 2019 (COVID-19) …

This literature review aimed to evaluate the effectiveness of rituximab (RTX) in patients with
systemic sclerosis (SSc). PubMed was searched for articles, published through 31 March …

Timing of vaccination and its relationship with concomitant immunosuppressive therapy has
been a matter of debate in the field of AutoImmune Inflammatory Rheumatic Diseases …

New evidence from 2022 slightly changed some perspectives for rheumatoid arthritis (RA)
management. Real-world data on the efficacy and safety of disease-modifying anti …